{
    "2021-06-18": [
        [
            {
                "time": "",
                "original_text": "CAR-T深度报告(一)：CAR-T概念及全球上市CAR-T疗法",
                "features": {
                    "keywords": [
                        "CAR-T",
                        "全球",
                        "上市",
                        "疗法"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196)：FCN-098胶囊用于晚期恶性肿瘤治疗开展临床试验获国家药监局批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "FCN-098",
                        "胶囊",
                        "临床试验",
                        "国家药监局"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：子公司获药品临床试验批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：复创医药抗肿瘤新药FCN-098胶囊获批临床",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复创医药",
                        "抗肿瘤",
                        "新药",
                        "FCN-098",
                        "胶囊",
                        "临床"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：子公司FCN-098胶囊获批开展临床试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "FCN-098",
                        "胶囊",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星系再度加码酒企投资 低度酒新锐成立1年两获融资",
                "features": {
                    "keywords": [
                        "复星系",
                        "酒企投资",
                        "低度酒",
                        "融资"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费品",
                        "酒业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}